Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.43 |
| ▸ | PLIN1 | O60240 | 1/20 | 0.43 |
| ▸ | BCHE | P06276 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.43 |
| ▸ | ACHE | P22303 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | PLIN5 | Q00G26 | 1/20 | 0.43 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.43 |
| ▸ | ABHD5 | Q8WTS1 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | CES2 | O00748 | 2/20 | 0.39 |
| ▸ | CES1 | P23141 | 2/20 | 0.39 |
| ▸ | DAO | P14920 | 1/20 | 0.39 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.39 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL893710 | 0.74 | CYP1B1 (0.61) | MAOBLMNAAKR1C1PLIN1BCHE | |
| SCHEMBL3848015 | 0.74 | CYP1B1 (0.61) | MAOBLMNAPLIN1BCHEMAPT | |
| SCHEMBL3848082 | 0.74 | ALDH1A1 (0.42) | MAOBLMNAAKR1C1PLIN1BCHE | |
| SCHEMBL3848018 | 0.74 | CYP1B1 (0.61) | MAOBLMNAPLIN1BCHEMAPT | |
| SCHEMBL3851044 | 0.72 | AKR1C1 (0.48) | MAOBLMNAAKR1C1PLIN1BCHE | |
| SCHEMBL3851043 | 0.72 | AKR1C1 (0.48) | MAOBLMNAAKR1C1PLIN1BCHE | |
| SCHEMBL12483197 | 0.70 | ALOX15 (0.41) | MAOBLMNAAKR1C1PLIN1BCHE | |
| SCHEMBL12483194 | 0.70 | ALOX15 (0.41) | MAOBLMNAAKR1C1PLIN1BCHE | |
| SCHEMBL11573032 | 0.69 | ALDH1A1 (0.48) | MAOBLMNAPLIN1MAPTRECQL | |
| SCHEMBL21268022 | 0.69 | ALDH1A1 (0.46) | MAOBLMNAPLIN1MAPTRECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230357488-A1 | CURABLE RESIN COMPOSITION | CANON KK (JP) | 2023-11-09 | — | — | US | claimed |
| US-20190177469-A1 | CURABLE RESIN COMPOSITION | CANON KABUSHIKI KAISHA (JP) | 2019-06-13 | — | — | US | claimed |
| EP-1412309-B1 | EPOXIDE STABILIZATION OF FLUOROPHOSPHITE-METAL CATALYST SYSTEM | EASTMAN CHEM CO (US) | 2015-04-29 | — | — | EP | claimed |
| EP-1412309-A2 | EPOXIDE STABILIZATION OF FLUOROPHOSPHITE-METAL CATALYST SYSTEM | EASTMAN CHEMICAL COMPANY (US) | 2004-04-28 | — | — | EP | claimed |
| US-6693219-B2 | PREVENTING FLUOROPHOSPHITE LIGANDS HYDROLYSIS BY ADDING AN EPOXIDE; CATALYTIC HYDROFORMYLATION OF ALPHA-OLEFIN, HYDROGEN, CARBON MONOXIDE FOR PRODUCING ALDEHYDES | EASTMAN CHEMICAL COMPANY | 2004-02-17 | — | — | US | claimed |
| US-20030018220-A1 | Preventing fluorophosphite ligands hydrolysis by adding an epoxide; catalytic hydroformylation of alpha-olefin, hydrogen, carbon monoxide for producing aldehydes | EASTMAN CHEMICAL COMPANY | 2003-01-23 | — | — | US | claimed |
| WO-2002098825-A2 | EPOXIDE STABILIZATION OF FLUOROPHOSPHITE-METAL CATALYST SYSTEM | EASTMAN CHEMICAL COMPANY (US) | 2002-12-12 | — | — | WO | claimed |
| US-20230357488-A1 | CURABLE RESIN COMPOSITION | CANON KK (JP) | 2023-11-09 | — | — | US | disclosed |
| US-20220325036-A1 | PROCESS FOR THE PREPARATION OF POLYESTERS WITH RECYCLED MONOMERS FROM PYROLYSIS AND METHANOLYSIS | EASTMAN CHEMICAL COMPANY (US) | 2022-10-13 | — | — | US | disclosed |
| US-20220281793-A1 | RECYCLE CONTENT (C4)ALKANAL | EASTMAN CHEMICAL COMPANY (US) | 2022-09-08 | — | — | US | disclosed |
| EP-4003950-A1 | RECYCLE CONTENT (C4)ALKANOIC ACID | Eastman Chemical Company (US) | 2022-06-01 | — | — | EP | disclosed |
| EP-4003948-A1 | RECYCLE CONTENT (C4)ALKANAL | Eastman Chemical Company (US) | 2022-06-01 | — | — | EP | disclosed |
| WO-2021021849-A1 | RECYCLE CONTENT (C4)ALKANOIC ACID | EASTMAN CHEMICAL COMPANY (US) | 2021-02-04 | — | — | WO | disclosed |
| US-20040054211-A1 | Process for reducing fluoride impurities resulting from use of fluorophosphite catalysts | EASTMAN CHEMICAL COMPANY | 2004-03-18 | — | — | US | disclosed |
| US-6693219-B2 | PREVENTING FLUOROPHOSPHITE LIGANDS HYDROLYSIS BY ADDING AN EPOXIDE; CATALYTIC HYDROFORMYLATION OF ALPHA-OLEFIN, HYDROGEN, CARBON MONOXIDE FOR PRODUCING ALDEHYDES | EASTMAN CHEMICAL COMPANY | 2004-02-17 | — | — | US | disclosed |
| EP-1017494-B1 | HYDROFORMYLATION PROCESS USING NOVEL PHOSPHITE-METAL CATALYST SYSTEM | EASTMAN CHEM CO (US) | 2004-01-21 | — | — | EP | disclosed |
| US-20030018220-A1 | Preventing fluorophosphite ligands hydrolysis by adding an epoxide; catalytic hydroformylation of alpha-olefin, hydrogen, carbon monoxide for producing aldehydes | EASTMAN CHEMICAL COMPANY | 2003-01-23 | — | — | US | disclosed |
| EP-1017494-A1 | HYDROFORMYLATION PROCESS USING NOVEL PHOSPHITE-METAL CATALYST SYSTEM | EASTMAN CHEMICAL COMPANY (US) | 2000-07-12 | — | — | EP | disclosed |
| WO-1999013984-A1 | HYDROFORMYLATION PROCESS USING NOVEL PHOSPHITE-METAL CATALYST SYSTEM | EASTMAN CHEMICAL COMPANY (US) | 1999-03-25 | — | — | WO | disclosed |
| US-5840647-A | Hydroformylation process using novel phosphite-metal catalyst system | EASTMAN CHEMICAL COMPANY (US) | 1998-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030018220-A1 | Preventing fluorophosphite ligands hydrolysis by adding an epoxide; catalytic hydroformylation of alpha-olefin, hydrogen, carbon monoxide for producing aldehydes | CYP2F1, CYP4F2, CYP4F11 | MAOB 230/4885LMNA 3994/4885AKR1C1 467/4885 |
| US-20040054211-A1 | Process for reducing fluoride impurities resulting from use of fluorophosphite catalysts | PPIP5K2, PFAS, NSF | MAOB 826/4885LMNA 1347/4885AKR1C1 3866/4885 |
| US-20220281793-A1 | RECYCLE CONTENT (C4)ALKANAL | ALKBH3, AKR1C4, CBR1 | MAOB 1470/4885LMNA 1467/4885AKR1C1 42/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.